These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1227752)

  • 41. Differential effect of amitriptyline and bupropion on primary and secondary depression: a pilot study.
    Othmer SC; Othmer E; Preskorn SH; Mac D
    J Clin Psychiatry; 1988 Aug; 49(8):310-2. PubMed ID: 3137218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Coronary arteries and myocardial perfusion in experimental acute vascular occlusion. Influence of pharmacological coronary dilatation].
    Hahn N; Felix R; Draznin N; Mayer R; Düx A; Sporbeck G
    Med Welt; 1971 Oct; 44():1738-40. PubMed ID: 5125834
    [No Abstract]   [Full Text] [Related]  

  • 43. [Results of Intencordin treatment of patients with coronary artery disease].
    Adamska-Dyniewska H; Goch JH; Gajewska B
    Wiad Lek; 1973 Oct; 26(20):1937-40. PubMed ID: 4587344
    [No Abstract]   [Full Text] [Related]  

  • 44. [Suppression of myocardial lipid peroxidation during preventive treatment of transitory coronary insufficiency with myophedrine].
    Litvitskiĭ PF; Kogan AKh; Kudrin AN; Luk'ianova LO; Ol'binskaia LI
    Farmakol Toksikol; 1981; 44(3):303-7. PubMed ID: 7286187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of coronary insufficiency. Clinical evaluation of a vasodilator agent and tranquilizer drug combination (Ro 4-6486)].
    Buzzi A
    Med Panam; 1963 Aug; 21(4):97-9. PubMed ID: 5900011
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral oxyfedrine on left ventricular performance in patients of ischaemic heart disease.
    Puri VK; Mehrotra A; Agarwal SK; Hasan M
    J Assoc Physicians India; 1985 Apr; 33(4):269-71. PubMed ID: 4030673
    [No Abstract]   [Full Text] [Related]  

  • 47. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    Wiad Lek; 1974 Mar; 27(5):463-6. PubMed ID: 4603373
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical testing of 2-benzofuryl-p-chlorophenylcarbinol].
    Guarino V; Federico P; Telesco R; Varriale A
    Minerva Cardioangiol; 1974 May; 22(5):323-31. PubMed ID: 4619186
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of Visken treatment of severe cases of coronary disease].
    Ilmurzyńska K; Ziólkowski L
    Pol Tyg Lek; 1973 Nov; 28(45):1774-6. PubMed ID: 4765947
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparison versus placebo, in the exercise test, of the efficacy of the transdermal administration of trinitroglycerin in stable coronary insufficiency].
    Gaudy MC; Waynberger M; Mothes P; Mathieu P; Jean-Louis P; Julien J; Serrurier D; Darragon T
    Ann Cardiol Angeiol (Paris); 1987 Nov; 36(9):513-6. PubMed ID: 3122630
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical evaluation of a spasmolytic drug, dimidin].
    Trusov VV; Pimenóv LT; Guseva LP
    Vrach Delo; 1975 Aug; (8):30-4. PubMed ID: 1221600
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical study of 1035 M.D. in the treatment of chronic coronary insufficiency. 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1968 Oct; ():Suppl 6:800-3. PubMed ID: 5748097
    [No Abstract]   [Full Text] [Related]  

  • 54. [Correction of extracardiac effects on the heart as a method of treating ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Litvitskiĭ PF; Bragina GI
    Farmakol Toksikol; 1982; 45(3):53-9. PubMed ID: 6284550
    [No Abstract]   [Full Text] [Related]  

  • 55. Two multicenter studies of the antidepressant effects of bupropion HCl versus placebo.
    Stern WC; Harto-Truax N
    Psychopharmacol Bull; 1980 Jul; 16(3):43-6. PubMed ID: 6773096
    [No Abstract]   [Full Text] [Related]  

  • 56. Observations with high Mydocalm doses in the treatment of internal diseases.
    Udvardi G
    Ther Hung; 1987; 35(1):23-7. PubMed ID: 3438860
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.
    Sheehan DV; Davidson J; Manschreck T; Van Wyck Fleet J
    J Clin Psychopharmacol; 1983 Feb; 3(1):28-31. PubMed ID: 6403599
    [No Abstract]   [Full Text] [Related]  

  • 58. [Critical review of clinical experimentation with clofibrate in coronary disease].
    Azzena D; Astengo F
    Minerva Cardioangiol; 1973; 21(7):497-502. PubMed ID: 4756344
    [No Abstract]   [Full Text] [Related]  

  • 59. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    World Health Organ Tech Rep Ser; 1974 Mar; 27(5):463-6. PubMed ID: 4206990
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of propafenone on coronary and systemic hemodynamics].
    Terrosu P; Ibba GV; Franceschino V; Contini GM; Delpini A
    G Ital Cardiol; 1986 Apr; 16(4):321-7. PubMed ID: 3743935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.